Grupo Ribera and Microsoft Partner to Promote Innovation and AI in the Healthcare Sector

Revolution in the health sector. Microsoft and the Ribera Group have announced a strategic collaboration to advance the use of cutting-edge technologies, such as Artificial Intelligence (AI) and Generative AI, in the field of health. This alliance aims to transform and improve patient care and the management of health services.

A fundamental aspect of this agreement is the application of Generative AI to simplify administrative tasks in the healthcare sector. These innovations have the potential to reduce administrative fatigue by freeing up time for healthcare staff, allowing them to focus and dedicate more time to patient care, according to the companies’ statement.

Read more about the partnership between Ribera Group and Microsoft and find the latest financial news of the day with the Born2Invest mobile app.

Ribera Group is committed to digitalization

In the words of Elisa Tarazona, CEO of the Ribera Group, “We are committed to offering the best possible medical care to our patients, and we are committed to digitalization, with the help of a leader like Microsoft, which will help us take an important step towards forward by taking advantage of the latest technologies; it has always been a close ally and, with the application of AI, we can take a disruptive leap in our processes, free up administrative time for our healthcare professionals and focus on what is most important: taking care of the health of our patients. people.”

In the health sector, the accumulated economic growth in the period 2022-2025 is estimated at $540 million

According to Alberto Granados, president of Microsoft Spain, “at Microsoft, we are committed to promoting the digital transformation of organizations in all industries.” The manager added that “AI has the potential to improve the health sector and medical care and accelerate scientific research.”

The agreement signed between Microsoft and Ribera also involves collaboration with Futurs, the technological subsidiary of the Ribera Group, which thus becomes a partner of the American multinational. The objective of Futurs is to respond to the needs of the population, transforming healthcare through innovation and technology. The subsidiary develops both its own solutions and co-innovation projects and offers IT consulting development, and operations services for healthcare institutions, both in Spain and abroad.

The cloud and the services it supports, such as Generative Artificial Intelligence, have become one of the main priorities for companies, as it is key to accelerating the digitalization of organizations and a fundamental pillar for the generation of income and cost reduction. In this sense, in the health sector, the accumulated economic growth in the period 2022-2025 is estimated at $540 million.

__

(Featured image by Efes via Pixabay)

DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.

This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.

First published in PlantaDoce. A third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.